doi: 10.1007/BF02123497.
Active immunization with feline leukemia virus envelope glycoprotein suppresses growth of virus-induced feline sarcoma
- PMID: 6304480
- DOI: 10.1007/BF02123497
Item in Clipboard
Active immunization with feline leukemia virus envelope glycoprotein suppresses growth of virus-induced feline sarcoma
Med Microbiol Immunol.
1983.
Abstract
The efficiency was examined of immunization with feline leukemia virus glycoprotein complexes (gp85 rosettes) to protect cats against tumors induced by feline sarcoma virus (FeSV). The glycoprotein was isolated from feline leukemia virus (FeLV). Young cats were vaccinated with the purified viral glycoprotein and challenged with FeSV (FeLV). FeLV gp85 antibody levels were measured by enzyme-linked immunosorbent assay and tumor volumes were determined. In immunized animals tumor development was reduced. Gp85 antibody levels before challenge were correlated inversely with tumor size (r2 = 0.79). This method appears to be suitable for fast and efficient testing of future FeLV vaccines.
Similar articles
-
Possible immunoenhancement of persistent viremia by feline leukemia virus envelope glycoprotein vaccines in challenge-exposure situations where whole inactivated virus vaccines were protective.Vet Immunol Immunopathol. 1986 Feb;11(2):123-48. doi: 10.1016/0165-2427(86)90093-0. Vet Immunol Immunopathol. 1986. PMID: 3008409 Free PMC article.
-
Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.J Natl Cancer Inst. 1980 Dec;65(6):1285-92. J Natl Cancer Inst. 1980. PMID: 6253714
-
Feline oncornavirus-associated cell membrane antigen: a viral and not a cellularly coded transformation-specific antigen of cat lymphomas.Virology. 1983 Jan 30;124(2):445-61. doi: 10.1016/0042-6822(83)90360-4. Virology. 1983. PMID: 6186079
-
Leukemia specific antigens: FOCMA and immune surveillance.Haematol Blood Transfus. 1979;23:453-86. doi: 10.1007/978-3-642-67057-2_60. Haematol Blood Transfus. 1979. PMID: 232469 Review.
-
Efficacy of an inactivated feline leukemia virus vaccine.AIDS Res Hum Retroviruses. 1996 Mar 20;12(5):379-83. doi: 10.1089/aid.1996.12.379. AIDS Res Hum Retroviruses. 1996. PMID: 8882314 Review.
Cited by
-
Synthesis and processing of human immunodeficiency virus type 1 envelope proteins encoded by a recombinant human adenovirus.J Virol. 1989 Jan;63(1):129-36. doi: 10.1128/JVI.63.1.129-136.1989. J Virol. 1989. PMID: 2535720 Free PMC article.
-
Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody.Proc Natl Acad Sci U S A. 1986 Sep;83(18):7023-7. doi: 10.1073/pnas.83.18.7023. Proc Natl Acad Sci U S A. 1986. PMID: 3018753 Free PMC article.
-
Possible immunoenhancement of persistent viremia by feline leukemia virus envelope glycoprotein vaccines in challenge-exposure situations where whole inactivated virus vaccines were protective.Vet Immunol Immunopathol. 1986 Feb;11(2):123-48. doi: 10.1016/0165-2427(86)90093-0. Vet Immunol Immunopathol. 1986. PMID: 3008409 Free PMC article.
-
Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine.Proc Natl Acad Sci U S A. 1987 Dec;84(23):8583-7. doi: 10.1073/pnas.84.23.8583. Proc Natl Acad Sci U S A. 1987. PMID: 3479807 Free PMC article.
-
Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120.J Virol. 1989 Dec;63(12):5046-53. doi: 10.1128/JVI.63.12.5046-5053.1989. J Virol. 1989. PMID: 2555541 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous